🇺🇸 FDA
Patent

US 8450337

Methods of treating skin disorders with caffeic acid analogs

granted A61KA61K31/203A61K31/44

Quick answer

US patent 8450337 (Methods of treating skin disorders with caffeic acid analogs) held by Moleculin, LLC expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Moleculin, LLC
Grant date
Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/203, A61K31/44, A61K31/59, A61K45/06